- Home
- PNI vs FORA Comparison
PNI vs FORA Comparison
Compare PNI & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PNI | FORA |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.8M | 69.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PNI | FORA |
|---|---|---|
| Price | $6.92 | $2.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.4K | ★ 36.0K |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | ★ 4.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $28,106,911.00 |
| Revenue This Year | N/A | $47.82 |
| Revenue Next Year | N/A | $10.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 37.47 |
| 52 Week Low | $6.03 | $1.64 |
| 52 Week High | $7.89 | $4.03 |
Technical Indicators
Market Signals| Indicator | PNI | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 46.87 | 47.02 |
| Support Level | $6.89 | $2.10 |
| Resistance Level | $6.99 | $2.21 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 50.00 | 42.61 |
Price Performance
Historical ComparisonAbout PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.